Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings

Lisa A de Jong, Jessie Groeneveld, Jelena Stevanovic, Harrie Rila, Robert G Tieleman, Menno V Huisman, Maarten J Postma, Marinus van Hulst

Onderzoeksoutput

1 Citaat (Scopus)
24 Downloads (Pure)

Vingerafdruk

Duik in de onderzoeksthema's van 'Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings'. Samen vormen ze een unieke vingerafdruk.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases